Core Viewpoint - The "Hongmeng Starry Night Gala," co-hosted by the China Central Radio and Television and the Guangdong Provincial Government, showcases China's technological self-reliance and collective aspirations for the future, themed "Together" [1]. Group 1: Event Overview - The gala aired on December 20, attracting over 200 media outlets and achieving a viewership of over 203 million, with 307 trending topics and a cumulative reading volume exceeding 1.1 billion [3]. - The event featured a central 18-meter "moon" made of 3,065 curved screens, symbolizing the future of the Hongmeng system, designed by Chen Yan, a prominent figure in art direction for major events [4]. Group 2: Artistic and Technical Excellence - The gala's production involved top talents from major events like the Olympics and Spring Festival, emphasizing high artistic standards and innovative broadcasting technology [4]. - The lighting design included a 31-meter diameter super light ring and 24-meter tall light towers, creating an immersive experience for the audience [4]. Group 3: Musical Contributions - The music director, Liu Zhuo, crafted unique arrangements for each song, with performances that resonated deeply with themes of struggle and pride, such as "Glorious Years" and "I Am Here" [6]. Group 4: Community and Cultural Significance - The event celebrated various contributors to technology and culture, highlighting individuals like Professor Qin Feizhou and CEO Wang Zhengnan, who embody the spirit of collaboration and innovation [7]. - The concept of "together" was emphasized as a metaphor for the interconnectedness of technology and daily life, with references to the collaborative nature of the Hongmeng ecosystem [9].

Core Viewpoint - Fangsheng Pharmaceutical has launched a new traditional Chinese medicine (TCM) product, "Yangxue Qufeng Zhitong Granules," which is the first TCM innovation drug targeting frequent tension-type headaches in China, enhancing the company's competitive edge in TCM innovation [1][2] Group 1: Product Launch and Development - The "Yangxue Qufeng Zhitong Granules" was officially launched on December 21, 2025, and is a significant achievement after over ten years of research and clinical trials [1] - This new drug is based on the classic formula "Shengxian Decoction" by renowned physician Zhang Xichun and received its drug registration certificate from the National Medical Products Administration in June 2025 [1] - Fangsheng Pharmaceutical has successfully developed three TCM innovation drugs since 2016, showcasing its leading capabilities in TCM innovation [1] Group 2: Sales and Future Plans - The company aims for the new TCM innovation drug to achieve over 100 million yuan in sales within two years and plans to launch 1-2 new TCM innovation drugs every 2-3 years [2] - The goal is to create a product matrix with multiple products generating annual sales of 300-500 million yuan, targeting a compound growth in performance over the next 3-5 years [2] Group 3: Ongoing Research and Development - Fangsheng Pharmaceutical has several TCM innovation drugs under development, including "Yiqi Xiaoliu Granules," "Ziying Granules," and "Fuke Zhi Xue Xiaotong Granules," with clinical trial approvals received [2] - Other ongoing projects include "Zhulong Tongluo Tablets," "Jianwei Qutong Pills," and "Sanhua Jiegou Pills," with "Xiaoer Jingxing Zhitong Granules" expanding to adult indications and "Jianwei Qutong Pills" currently in phase III clinical trials [2] Group 4: Strategic Focus on Industrial Hemp - Industrial hemp is a key focus in the company's development strategy, with its subsidiary, Yunnan Fuya Biotechnology Co., achieving large-scale production of high-purity CBD and related products [2] - The subsidiary has begun overseas sales, with revenue nearing 20 million yuan in the first three quarters of 2025, showing significant growth and a reduction in operating losses [2] - The company anticipates that its annual revenue will exceed 30 million yuan for the first time [2]

"死磕降本是生猪养殖企业的当务之急。"这已成为2025年生猪养殖企业的生存共识。 新五丰是国内较早的生猪规模化养殖实践者，一直将生猪养殖作为公司重点发展的核心业务。近年 来，公司以生猪养殖为基础，通过机制创新，提质增效，降低成本，正在探索生猪养殖高质量发展之 路。 降低成本，提升生猪生产成本竞争力 面对猪价跌跌不休、产能去化远水难解近渴，猪企的当务之急还是死磕降本。 "今年3月开始，随着玉米价格的上涨，我们饲料用料由玉米切换到小麦，每吨饲料节约了50元左 右，通过饲料配方的切换，饲料成本优化空间达到了5%，上半年光饲料成本节约了2700万元。"新五丰 分管饲料板块的周庆华副总经理说。 目前，新五丰的饲料板块的技术团队，从营养技术提高、本地资源替代蛋白饲料、分阶段精细管理 营养等多方面降低饲料成本，不断提升公司行业竞争力。 衡南晟峰母猪场是新五峰的母猪标杆场，位于衡南县花桥镇，母猪设计规模1.2万头。衡南晟峰的 场长赵菊文说，控制成本是我们猪场的重要工作之一，精准控制喂料成本、强化内部考核遏制浪费行 为、培养饲养人员责任心等多方面都在降低成本。 "针对这个生长阶段仔猪的营养需求，要采用少食多餐的方式喂养，减少饲 ...

12月19日，中国民营经济研究会第六次会员大会在北京召开。全国政协副主席、全国工商联主席高云龙，全国工商联党组成 员、副主席王受文出席大会。 当天下午，研究会召开了会长会议，谋划新一届理事会工作思路进行研讨。 副会长耿福能结合企业经营实践和经济思考，提出经济生态系统的"生物多样性理论"。他表示，"十四五"时期，医药健康行业 正从"跟跑""并跑"向"领跑"迈进。站在"十五五"新起点，要牢牢把握战略机遇，坚持科技创新，发展新质生产力，建立完善经济 生态系统，以长期主义培育具有国际竞争力的中国原创好药、民族强药。 中国民营经济研究会成立于1993年，是在民政部登记注册、专门从事民营经济研究的全国性、学术性、非营利社会组织，业务 主管单位为全国工商联。研究会理事会员由各部委和地方工商联推荐，涵盖政、商、学、研各界代表。近年来，研究会围绕"两 个健康"主题，打造了"中国民营经济发展论坛"等一系列品牌活动，设立台州、泉州民营经济研究基地，积极发挥民营经济研 究"国家队"的作用。（潘安） 会议全面总结2025年度工作，系统谋划2026年重点任务，审议通过有关事项，并选举产生新一届理事会领导机构。高云龙主席 在讲话中充分肯定 ...

Core Viewpoint - The "Financial Enterprises Gansu Tour and Investment Financing Conference" has entered the stage of on-site enterprise investigation, marking a significant step in the integration of capital, technology, finance, and industry in Gansu province [1]. Group 1: Event Overview - The event is co-hosted by various financial and regulatory bodies in Gansu, including the Provincial Financial Office and the People's Bank of China Gansu Branch [1]. - A delegation, including representatives from major financial institutions, visited the Lanzhou Stone Group and Lanzhou Stone Zhongke to explore potential collaborations [3]. Group 2: Company Insights - Lanzhou Stone Zhongke showcased its innovative technology in the field of nanomaterials, highlighting its clear path towards industrialization driven by technological innovation [3]. - The company has achieved national-level awards for its technological achievements and has successfully commercialized several product cases [3]. Group 3: Strategic Collaboration - A strategic cooperation agreement was signed between Lanzhou Stone Zhongke and Guotai Junan Securities, emphasizing comprehensive collaboration on technology transfer and capital synergy [5]. - Both parties agreed to establish a nanomaterial industry fund, aiming to enhance the transformation of technological achievements and accelerate the development of a virtuous cycle between technology, industry, and finance in Gansu [5]. Group 4: Impact and Recognition - The conference provided a provincial platform for Lanzhou Stone Zhongke to showcase its strengths, significantly enhancing its influence and visibility in the financial investment community [5]. - The participation of multiple financial institutions in the investigation reflects a strong recognition of Lanzhou Stone Zhongke's long-term commitment to the new materials sector [5].

上海徐汇区在"十四五"时期生物医药产业成果显著，累计获批药械产品198款，产业规模突破千亿 元，其中人工智能相关产品8个，位居全市前列。中惠医疗依托区域政策与产业生态，实现从技术攻坚 到临床落地的跨越发展。其自主研发的"双能相控聚焦超声技术"已申报国家三类创新医疗器械，融合人 工智能等多项创新。 日前，"智领医械·创新未来"人工智能医疗器械创新发展大会在上海举行，人工智能医疗器械联盟 正式揭牌成立。该联盟汇聚监管部门、临床机构及行业龙头企业，致力于打通"技术研发—临床验证— 产品应用"全链条，破解人工智能医疗器械在数据合规、审评审批等方面的共性难题。 编辑：宋杰 中惠医疗作为超声治疗领域领军企业，成功入选联盟首批成员。创始人兼CEO朱威桢表示，中惠医 疗以相控阵列聚焦超声技术为核心，为肿瘤患者提供更安全、高效的治疗方案，并通过构建开放生态推 动行业技术跃升。 公司即将推出全球首款双能相控聚焦超声治疗机器人，集成相控、双能、影像、系统控制及数字化 平台技术，实现全自研融合，预计一至两年内应用于乳腺癌等疾病的临床无创治疗。 朱威桢指出，借助联盟平台，中惠医疗将更高效对接临床资源，加速技术验证，并推动MOS开放 平 ...

"作为从这片土地成长起来的企业，我们始终牢记社会责任。"上上电缆集团相关负责人在捐赠仪式上说，此次捐赠基于企业长 期关注乡村发展的战略思考，希望通过方里书房这个项目，为乡亲们搭建优质精神家园，让文化的种子在乡村生根发芽、开花 结果。 市慈善总会相关负责人指出，乡村振兴既要实现物质富裕，也要追求精神丰盈。未来，市慈善总会将持续关注方里书房的运营 与发展，积极推动更多企业与乡村开展深度联动，共同探索文化赋能乡村振兴的有效路径，让文明之光照亮乡村的每一个角 落。（邹迪） 12月18日，江苏上上电缆集团联合溧阳市慈善总会，向昆仑街道方里村捐赠80万元专项资金，专项用于方里书房文化设施建 设，为村民打造一座集阅读、交流、学习于一体的现代化精神家园。 ...

Core Viewpoint - The introduction of the "Internet Platform Pricing Behavior Rules" marks a significant step towards institutionalizing and refining price governance in China's platform economy, aiming to protect the rights of consumers and operators while promoting a healthy market environment [3] Group 1: Regulatory Framework - The "Behavior Rules" aim to establish a normalized price regulation mechanism for internet platforms, ensuring compliance with pricing behaviors and protecting the legitimate rights of consumers and operators [1] - The rules were developed after public consultation, focusing on standardizing pricing behavior, enhancing transparency, and fostering collaboration among stakeholders to create a healthy platform ecosystem [2] Group 2: Key Provisions - The rules specify that platform operators must respect the pricing autonomy of platform operators and cannot impose unreasonable restrictions or conditions on their pricing behaviors [2][4] - The rules require clear price marking, including the disclosure of dynamic pricing, differential pricing, and promotional rules, while regulating subsidy and promotional activities [4] - The rules prohibit unfair pricing practices such as predatory pricing, price discrimination, collusion, price gouging, and price fraud to maintain a fair competitive order [4][5] Group 3: Consumer Protection - The rules mandate that operators provide clear options for services like automatic renewals and one-click cancellations, ensuring consumers are well-informed and can easily opt-out of services [4][5] - The rules address issues like "big data pricing" and require the disclosure of algorithm rules to prevent unjustified price differences for the same transactions [5] Group 4: Implementation and Compliance - The "Behavior Rules" will take effect on April 10 of the following year, with platforms required to conduct self-assessments against the regulatory requirements before implementation [6] - Platform operators are expected to refine their internal compliance systems in line with the rules, particularly regarding consumer price rights and the autonomy of platform operators [7] Group 5: Collaborative Governance - Effective implementation of the rules requires a collaborative effort among government, platforms, industries, and society, with a focus on enhancing operational feasibility through detailed supporting policies [8] - Platforms are encouraged to shift from passive compliance to proactive governance, including internal audits and establishing transparent pricing complaint channels [8]

党的十八大以来，我国不断提升国内供给质量水平，持续释放消费和投资需求，内需对经济发展的支撑作用明显增强，是拉动我国经济增长的主动力 和稳定锚。2013—2024年，我国经济保持了年均6.1%的增长，内需对经济增长的平均贡献率达93.1%，其中最终消费支出和资本形成总额的平均贡献率分 别为55%和38.1%，消费的基础作用和投资的关键作用进一步发挥。 今年前三季度，最终消费支出对经济增长贡献率达53.5%，比上年全年提升9个百分点，继续发挥经济增长主引擎作用。 我国消费向新而行，新能源汽车销量连续10年全球第一。服务性消费占居民人均消费支出的比重从2013年的39.7%提高到2024年的46.1%。投资向优 发力，高技术产业投资持续多年快速增长，2018—2024年年均增长12.1%。 当前，世界百年未有之大变局加速演进，必须坚定实施扩大内需战略，以内需的稳定发展对冲外需的不确定性。 要准确把握国内市场发展规律，充分发挥内需对经济发展的支撑作用。统筹稳就业、稳企业、稳市场、稳预期，进一步做强国内大循环，有效应对外 部冲击挑战，推动我国经济平稳健康可持续发展。 中央经济工作会议着眼于确保"十五五"开好局、起好步， ...

Group 1: Core Insights - The People's Bank of China imposed penalties on three banks for various regulatory violations, including account management and financial statistics [1][2][4][6] - China Merchants Bank was fined 67.8343 million yuan for 11 violations, including failure to comply with customer identity verification and transaction reporting [2] - Industrial and Commercial Bank of China was fined 39.615 million yuan for 10 violations, with penalties imposed on 17 responsible individuals [4][5] - Shanghai Pudong Development Bank was fined 15.6 million yuan for imprudent management of wealth management and sales activities, with multiple individuals facing industry bans [6] Group 2: Specific Violations - Traffic Bank's violations included failure to manage accounts properly, non-compliance with currency management regulations, and not reporting large or suspicious transactions [2] - Industrial and Commercial Bank of China's violations included breaches in financial statistics, account management, and customer identity verification [4][5] - Shanghai Pudong Development Bank's issues stemmed from inadequate management of wealth management and sales operations, leading to penalties for several employees [6] Group 3: Responses from Banks - Traffic Bank acknowledged the penalties and stated that it has completed rectification work and is committed to enhancing compliance and internal controls [3] - Industrial and Commercial Bank of China expressed its commitment to addressing the root causes of the violations and improving risk management and compliance practices [5] - Shanghai Pudong Development Bank's penalties included significant bans on several employees, indicating serious management failures [6]